LataMed AI Corp. (OTC: LMED), a healthcare technology company developing digital health and artificial intelligence solutions for Latin America, announced today that it has entered into separate agreements with Colegio Claret and Colegio Roraima in Caracas, Venezuela, to develop and implement school-based digital healthcare initiatives. These partnerships are designed to provide students, parents, school personnel, and other authorized community members with access to online medical appointment scheduling, telemedicine consultations, and healthcare information through the company's platform.
Under the agreements, LataMed AI and each school will collaborate on an implementation framework that includes operational, technical, privacy, consent, and safeguarding procedures. The company intends to work with the schools to define the program's scope, establish enrollment and communication protocols, identify available healthcare services, and coordinate training for administrators and families. Participation by students will require parental or legal guardian authorization and comply with privacy laws, school policies, clinical protocols, and regulatory requirements.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., emphasized the strategic importance of partnering with educational institutions. “Schools are important centers of communication for families and communities,” he said. “Our objective is to work with Colegio Claret and Colegio Roraima to implement responsible programs that improve awareness of telemedicine services and make it easier for families to connect with qualified healthcare providers.”
Management believes that working through trusted educational institutions provides an efficient way to introduce digital healthcare services. The proposed model aims to facilitate coordinated communication among families, school administrators, and healthcare providers, demonstrating how LataMed AI's technology can be adapted for institutional healthcare-access programs. This approach aligns with the company's broader healthcare ecosystem strategy, which focuses on connecting patients, healthcare professionals, pharmacies, insurers, payment providers, wellness organizations, and educational institutions.
If successfully implemented, the model developed with Colegio Claret and Colegio Roraima could potentially be adapted for other educational institutions in Venezuela and across Latin America. However, any future expansion would depend on separate discussions, agreements, operational readiness, regulatory considerations, and the availability of qualified healthcare providers. The agreements establish the framework but do not guarantee a specific implementation schedule, participation levels, revenue generation, or expansion.
The company is also developing artificial intelligence-supported platforms—CardioAI, PulmoAI, and NeuroAI—to assist healthcare professionals in evaluating cardiovascular, pulmonary, and neurological health information. These platforms remain subject to continued development, testing, regulatory requirements, and commercial implementation. For more information about LataMed AI and its initiatives, visit https://latamed.ai or review filings with the U.S. Securities and Exchange Commission at www.sec.gov.
